Chagas' disease and cutaneous leishmaniasis are widespread in Central and South America and occur in individuals infected with the protozoa Trypanosoma cruzi and Leishmania braziliensis or L. mexicana, respectively. Immunological mechanisms are thought to be responsible for some pathological manifestations of these diseases. Patient sera usually contain strong antibody titers against the parasites (3, 10) , but also quite frequently contain antitissue antibodies which react with endocardium, blood vessels, and ensheathed peripheral nerves in Chagas' disease (7, 12) and with skin in American cutaneous leishmaniasis (ACL) (5) . These antibodies may be involved in certain autoimmune reactions which have been demonstrated in both diseases (8, 11) .
Recent studies have shown that sera from patients with Chagas' disease or ACL contain distinct antibody titers against the ubiquitously occurring basement membrane protein laminin (2, 13) . No antibodies could be detected so far against other extracellular matrix proteins such as various types of collagens, fibronectin, and proteoglycans. Immunoadsorption on laminin removed all tissue reactivity from Chagas' disease sera (13) , indicating that this protein is the major autoantigen involved. The nature and distribution of epitopes recognized by patient antibodies are still not known. It was argued that they are present on laminin material acquired by the parasites from host tissues or that the parasite and laminin share common epitopes (13) . The latter interpretation was recently supported by immunoelectron microscopic localization of laminin epitopes to various forms of the parasites (4) .
In the present study we examined the possibility of the presence of similar epitopes on other basement membrane proteins such as nidogen. This protein was initially isolated as an 80-kilodalton fragment (15) Paris, France. Inhibition of enzyme immunoassays by preincubation with soluble antigens followed a previously used procedure (17) . Radioimmunoassays were used for binding and inhibition tests and were performed according to standard protocols (14) . Immune complexes were precipitated by using a pretested excess of sheep antiserum against human immunoglobulin (Cohn fraction II) kindly provided by H. Nowack, Munich, Federal Republic of Germany. Affinity chromatography on nidogen and laminin immunoadsorbents followed established procedures (14) . In these experiments 0.3 ml of serum was passed over columns containing 0.5 to 1 mg of antigen and tested in radioimmunoassays prior to and after passage. Absorption procedures. Patient sera were absorbed with guinea pig or human blood group 0 or A erythrocytes, using 2 volumes of packed cells per volume of 1:5-diluted serum. Further absorptions were done with T. cruzi epimastigotes or L. mexicana or L. braziliensis promastigotes, which were grown as previously described (1), or with L. mexicana amastigotes, which were isolated from nodules of experimentally infected hamsters (9) . Absorptions and retesting by enzyme immunoassays were carried out as previously described (2).
RESULTS
Detection of antibodies to nidogen in patient sera. Screening by enzyme immunoassay of a large number of sera from patients with chronic Chagas' disease and ACL demonstrated significantly elevated levels of antibodies against nidogen when compared with a healthy control group (Table  1) . The levels of antibodies exceeded the upper limit in the control group (mean plus 2 standard deviations) in 49% of Chagas' disease patients and 70% of ACL patients. Sera from patients with several other inflammatory diseases did not differ in immunoreactivity for nidogen from the healthy Table 2 ). The enhanced reactivity in enzyme immunoassays was confirmed for selected groups of patients in radioimmunoasssays, using 1251I-labeled nidogen. Significantly higher binding was observed at all dilutions of patient sera when compared with a group of normal subjects (Fig. 1) . Maximum binding, however, did not exceed 20% of the labeled antigen added, while usually 80 to 90% are bound by rabbit antisera to nidogen (15) .
Comparison of immunoreactivity against nidogen and laminin. Previous studies have demonstrated that sera from Chagas' disease and ACL patients also contain a large proportion of distinct antibody titers against laminin (2, 13) . A comparison of two panels of ACL patient sera (n = 27 and 15) which showed strong binding in laminin radioimmunoassays in 55 and 87% of the cases, respectively, also revealed a large proportion of distinct binding to nidogen. Since the correlation of positive reactions with both antigens was rather high (.90%), a close relationship of epitopes recognized by the patient antibodies on laminin as well as nidogen was suggested.
Further evidence for this relationship was obtained in inhibition and immunoadsorption studies. A comparison of ACL sera in a radioimmunoinhibition assay demonstrated distinct and complete inhibition by both laminin and nidogen, regardless of whether a particular serum was reacted against labeled laminin or nidogen (Fig. 2) . Differences were noted, however, in the inhibitory capacity of both antigens, which was consistently 3-to 10-fold lower for nidogen when compared on a molar basis with that of laminin. A similar relationship could be demonstrated in inhibiting the reaction in enzyme immunoassays, except that the blocking action of nidogen was even more reduced by a factor of 30 to 100 (Fig. 3a and c) . 
ANTIBODIES TO NIDOGEN IN CHAGAS' DISEASE AND ACL
The high cross-reactivity of patient antibodies for laminin and nidogen is in contrast to data obtained with rabbit antisera raised against each individual protein. Inhibition tests of enzyme immunoassays specific for each protein failed to show any cross-reactivity for the other antigen even when applied in 100-to 1,000-fold molar excess compared with the antigen used for raising the antiserum (Fig. 3b and  d) . Similar data have been obtained previously in radioimmunoinhibition assays (15) . The data demonstrate the high purity of the antigens used in the present study, indicating a contamination of laminin by nidogen (and vice versa) by <0.1 to 1%.
Confirmation of the inhibition data was obtained by immunoadsorption. Passage of an ACL serum over a laminin column diminished the initial high laminin binding (plateau at 50%) to a background binding of 10 to 15%. Binding to nidogen was reduced in a similar fashion from about 17 to 2% (Fig. 4) . If the same antiserum was passed over a column containing nidogen, again binding to both antigens was reduced to the low levels observed with normal sera (data not shown).
Absorption on parasites and erythrocytes. Samples of Chagas' disease and ACL patient sera were examined by enzyme immunoassays for nidogen prior to and after absorption. Antibody reactivity could be completely abolished by L. mexicana and L. braziliensis amastigotes and promastigotes, by T. cruzi epimastigotes, and by guinea pig erythrocytes. No decrease in antibody activity was found after incubation with human blood group 0 and A erythrocytes.
DISCUSSION
The data obtained with enzyme and radioimmunoassays demonstrate that humans infected with either of two different members of the family Trypanosomatidae possess antibodies reacting with the basement membrane protein nidogen. This is, to our knowledge, the first report on the existence of such antibodies in human disease. Antibody levels above the upper limit of the normal range could be detected in 50 to 70% of the patients, a frequency comparable to that observed for antibodies reacting with laminin (2, 13). The occurrence of antinidogen antibodies is apparently due to the Trypanosomatidae infection since the antibodies could be removed from sera by incubation with the respective parasites. Furthermore, similar aptibody levels could not be detected in 11 different infectious or inflammatory diseases other than Chagas' disease or ACL.
Evidence indicates that the majority of antibodies which bind to nidogen also cross-react with laminin. This was clearly demonstrated by inhibition assays as well as immunoadsorption experiments. This observation suggests that the epitopes shared by nidogen and laminin are not genetically determined protein structures rather than posttranslational modifications common to both proteins. Patient antibodies differ in specificity, therefore, from rabbit antibodies raised experimentally which demonstrated unique epitopes on each of both proteins. Such rabbit antisera, however, may also contain a presumably sma,l1 crossreacting antibody fraction which cannot be detected by inhibition assays but is able to react with parasite structures, as shown by immunostaining of Trypanosomatidae with antilaminin antisera (4) .
The chemical nature of the epitopes recognized on basement membrane proteins by patients' antibodies has not yet been identified. Preliminary data indicate that they are stable against complete reduction of disulfide bonds and partially stable against treatmnents with pronase or alkali, but destroyed by periodate oxidation or acid hydrolysis (J. L. Avila, A. Szarfman, and R. Timpl, unpublished data). This suggests that the epitopes are glycoconjugates. However, binding and inhibition studies demonstrated a lower reactivity of patient antibodies for nidogen than for laminin. This could indicate lower amounts or a lower antibody affinity for the epitopes present on nidogen. Our data showed a more efficient absorption of nidogen imiunoreactivity on parasites and guinea pig erythrocytes, which as shown previously were rather inefficient in removing laminin immunoreactivity from patient sera (2) . Whether this reflects variations in antibody 4ffinity, heterogeneity of the shared epitopes, or the presence of additional antibodies specific for nidogen in the patients is not yet clear.
Two hypotheses have been suggested to explain the production of anti-basement membrane antibodies in patients with Trypanosomatidae infections (13) . It was considered that either certain parasites may possess surface antigens which cross-react with basement membrane proteins of the host or the parasites may incorporate blood vessel antigens into their surface by a mechanism similar to that recently reported for other host cell proteins (6) . The second possibility could explain the simultaneous occurrence of antibodies against nidogen and laminin since both proteins are considered to form stable complexes in situ (Dziadek and Timpl, in press; Dziadek et al., in press). Other data, however, favor the first hypothesis. Trypomastigotes which have been kept for long periods in cell culture without contact with the basement membrane laminin still react in immunogold staining with rabbit antisera against laminin (4). The observation that T. cruzi epimastigotes which have not been exposed to host tissues can at least remove the antinidogen immunoreactivity from patient sera also argues against the incorporation mechanism. This would be compatible also with the possible glycoconjugate nature of the epitopes which are more likely to be shared by parasites and vertebrate proteins than by protein sequences.
